Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Tabe

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
International Journal of Clinical Oncology|November 14, 2018
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid LeukemiaSamarpana Chakraborty, Claudia Morganti, Bianca Rivera Pena, et al.
Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.
Plos One|December 14, 2022
Establishment of preanalytical conditions for microRNA profile analysis of clinical plasma samplesKuno Suzuki, Tatsuya Yamaguchi, Masakazu Kohda, et al.
Biomedicines|October 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to EthnicityBeate Heissig, Yousef Salama, Roman Iakoubov, et al.
Nature Medicine|June 13, 2018
An inhibitor of oxidative phosphorylation exploits cancer vulnerabilityJennifer R Molina, Yuting Sun, Marina Protopopova, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
International Journal of Clinical Oncology|November 14, 2018
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)Shin Fujisawa, Yasunori Ueda, Kensuke Usuki, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid LeukemiaSamarpana Chakraborty, Claudia Morganti, Bianca Rivera Pena, et al.
Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.
Plos One|December 14, 2022
Establishment of preanalytical conditions for microRNA profile analysis of clinical plasma samplesKuno Suzuki, Tatsuya Yamaguchi, Masakazu Kohda, et al.
Biomedicines|October 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to EthnicityBeate Heissig, Yousef Salama, Roman Iakoubov, et al.
Nature Medicine|June 13, 2018
An inhibitor of oxidative phosphorylation exploits cancer vulnerabilityJennifer R Molina, Yuting Sun, Marina Protopopova, et al.
Pageof 16